Skip to main content

Table 3 Demography, outcome, admission hematology, coagulopathy and blood transfusion in massively transfused patients (> 10 RBC the initial 0-24 h) in each study period (2001-3 and 2005-7).

From: Blood product ratio in acute traumatic coagulopathy - effect on mortality in a Scandinavian level 1 trauma centre

   Study period
2001-3
Study period
2005-7
P-value1
n   21 45  
Age years 50 (35-69) 40 (28-52) 0.106
Gender male 16 (76%) 32 (71%) 0.666
ISS score 26 (17-34) 27 (19-36) 0.694
Mortality deceased 7 (37%) 17 (39%) 0.893
Hemoglobin mmol/l 5.7 (4.6-6.8) 6.7 (5.6-7.6) 0.066
Platelet count < 150*109/l 8 (53%) 17 (44%) 0.520
APTT > 35 s 9 (60%) 24 (62%) 0.917
INR > 1.2 11 (73%) 21 (54%) 0.192
Time to first blood product min 28 (22-65) 3 (0-23) < 0.001
RBC 0-6 h n 12 (12-24) 20 (14-30) 0.0394
RBC total n 14 (12-23) 20 (14-30) 0.0933
FFP 0-6 h n 5 (4-10) 14 (10-20) < 0.001
FFP total n 6 (4-12) 14 (10-21) < 0.001
PLT 0-6 h n 0 (0-1) 6 (4-8) < 0.001
PLT total n 0 (0-2) 6 (4-8) < 0.001
FFP:RBC 0-6 h ratio 0.33 (0.16-0.53) 0.71 (0.59-0.85) < 0.001
FFP:RBC total ratio 0.36 (0.24-0.59) 0.74 (0.61-0.85) < 0.001
PLT:RBC 0-6 h ratio 0 (0-0.05) 0.29 (0.20-0.37) < 0.001
PLT:RBC total ratio 0 (0-0.05) 0.29 (0.20-0.35) < 0.001
PLT:FFP 0-6 h ratio 0 (0-0.10) 0.40 (0.36-0.43) < 0.001
PLT:FFP total ratio 0 (0-0.13) 0.40 (0.35-0.46) < 0.001
  1. 1Patients from period 1 and 2 were compared by Wilcoxon Rank Sum test. Data are presented as medians (IQR), with p-values in bold for variables with p < 0.05.